Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NVS

Novartis

$77.08

-0.07 (-0.09%)

, LMNX

Luminex

$27.19

0.8 (3.03%)

07:30
05/21/18
05/21
07:30
05/21/18
07:30
Conference/Events
UBS to hold a conference »

Global Healthcare…

NVS

Novartis

$77.08

-0.07 (-0.09%)

LMNX

Luminex

$27.19

0.8 (3.03%)

MTEM

Molecular Templates

$7.30

-0.045 (-0.61%)

AMRX

Amneal Pharmaceuticals

$17.14

0.36 (2.15%)

DCPH

Deciphera

$25.29

-0.5 (-1.94%)

HSIC

Henry Schein

$71.93

-0.35 (-0.48%)

MNOV

MediciNova

$9.88

-0.54 (-5.18%)

ANGO

AngioDynamics

$20.08

0.29 (1.47%)

SURF

Surface Oncology

$14.19

0.19 (1.36%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

OBLN

Obalon Therapeutics

$2.63

0.03 (1.15%)

HIIQ

Health Insurance Innovations

$29.10

0.6 (2.11%)

JNJ

Johnson & Johnson

$124.27

0.45 (0.36%)

FLDM

Fluidigm

$5.75

-0.04 (-0.69%)

MRNS

Marinus Pharmaceuticals

$4.64

0.08 (1.75%)

ADUS

Addus HomeCare

$52.95

-0.15 (-0.28%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

ENDP

Endo

$6.11

-0.09 (-1.45%)

ONCE

Spark Therapeutics

$76.72

0.77 (1.01%)

MOR

MorphoSys

$26.33

-0.29 (-1.09%)

RTIX

RTI Surgical

$4.65

0.1 (2.20%)

IART

Integra LifeSciences

$64.62

0.54 (0.84%)

NVTA

Invitae

$6.80

0.26 (3.98%)

BTAI

BioXcel Therapeutics

$10.44

(0.00%)

WST

West Pharmaceutical

$89.25

0.845 (0.96%)

TTPH

Tetraphase

$3.67

0.02 (0.55%)

ESPR

Esperion

$42.13

-0.71 (-1.66%)

ALKS

Alkermes

$46.27

0.25 (0.54%)

FVE

Five Star Senior Living

$1.15

(0.00%)

IOVA

Iovance Biotherapeutics

$17.00

0.65 (3.98%)

SGRY

Surgery Partners

$18.80

-0.6 (-3.09%)

PKI

PerkinElmer

$75.56

1.14 (1.53%)

ICPT

Intercept

$72.48

1.35 (1.90%)

ATNX

Athenex

$16.97

(0.00%)

MMSI

Merit Medical

$53.70

1.05 (1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 29

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 01

    Jun

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 19

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Aug

  • 10

    Sep

  • 31

    Jan

Over a week ago
TTPH

Tetraphase

$3.75

0.05 (1.35%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55
Conference/Events
Tetraphase management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 21

    May

  • 28

    Aug

TTPH

Tetraphase

$3.70

0.27 (7.87%)

05:39
05/15/18
05/15
05:39
05/15/18
05:39
Conference/Events
Tetraphase management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 16

    May

  • 21

    May

  • 28

    Aug

TTPH

Tetraphase

$3.66

0.44 (13.66%)

, JNJ

Johnson & Johnson

$124.37

0.17 (0.14%)

13:06
05/07/18
05/07
13:06
05/07/18
13:06
Hot Stocks
Tetraphase jumps almost 15% after report on antibiotic effectiveness »

Shares of antibiotic…

TTPH

Tetraphase

$3.66

0.44 (13.66%)

JNJ

Johnson & Johnson

$124.37

0.17 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

  • 15

    May

  • 16

    May

  • 21

    May

  • 28

    Aug

TTPH

Tetraphase

$3.14

-0.13 (-3.98%)

16:47
05/03/18
05/03
16:47
05/03/18
16:47
Earnings
Tetraphase reports Q1 EPS (42c), consensus (42c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 16

    May

  • 21

    May

  • 28

    Aug

Over a month ago
TTPH

Tetraphase

$2.91

0.06 (2.11%)

08:59
03/29/18
03/29
08:59
03/29/18
08:59
Upgrade
Tetraphase rating change at Gabelli »

Tetraphase upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

TTPH

Tetraphase

$2.75

0.04 (1.48%)

16:41
03/06/18
03/06
16:41
03/06/18
16:41
Earnings
Tetraphase reports Q4 EPS (46c), consensus (64c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

TTPH

Tetraphase

$2.69

-0.12 (-4.27%)

16:11
03/01/18
03/01
16:11
03/01/18
16:11
Hot Stocks
Tetraphase promotes Edwards to COO »

Tetraphase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

TTPH

Tetraphase

$2.87

0.67 (30.45%)

11:55
02/27/18
02/27
11:55
02/27/18
11:55
Recommendations
Tetraphase analyst commentary at Piper Jaffray »

Tetraphase eravacycline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

TTPH

Tetraphase

$2.87

0.67 (30.45%)

08:07
02/27/18
02/27
08:07
02/27/18
08:07
Hot Stocks
Tetraphase announces FDA acceptance of NDA submission for Eravacycline »

Tetraphase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.